Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Sanofi (SNY) over the last 5 years, with Q4 2025 value amounting to -$54.7 million.

  • Sanofi's Exchange Rate Effect fell 29386.73% to -$54.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$163.8 million, marking a year-over-year decrease of 16260.72%. This contributed to the annual value of -$53.1 million for FY2025, which is 27749.33% down from last year.
  • According to the latest figures from Q4 2025, Sanofi's Exchange Rate Effect is -$54.7 million, which was down 29386.73% from -$63.1 million recorded in Q3 2025.
  • In the past 5 years, Sanofi's Exchange Rate Effect registered a high of -$5.4 million during Q1 2024, and its lowest value of -$63.1 million during Q3 2025.
  • In the last 3 years, Sanofi's Exchange Rate Effect had a median value of -$23.0 million in 2025 and averaged -$28.3 million.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first soared by 5965.23% in 2024, then tumbled by 29386.73% in 2025.
  • Sanofi's Exchange Rate Effect (Quarter) stood at -$34.4 million in 2023, then skyrocketed by 59.65% to -$13.9 million in 2024, then plummeted by 293.87% to -$54.7 million in 2025.
  • Its Exchange Rate Effect was -$54.7 million in Q4 2025, compared to -$63.1 million in Q3 2025 and -$24.9 million in Q2 2025.